top of page
Screenshot 2021-09-15 at 10.58_edited.jpg

We at Pharmista Technologies are on a mission to disrupt the pregnancy testing market which has not been reinvented in over 30 years. To achieve this, we are developing a reusable pregnancy test that is based on a patented platform technology, enabling repeated detection of the target analyte. With 90 % of women being interested in replacing todays solutions with our innovation, we are dedicated towards realising this product in the best possible way!

Screenshot 2021-09-10 at 14.25.26.png


In order to gain information about the most important happening, experience and choice in a persons life, women have been turning to the at-home pregnancy test for decades. The problem is that available tests are either expensive per use or poor in quality, aside from being single-use only. This ultimately leads to many needs being unmet, where this problem is related to incumbents fear of jeopardising stable revenue streams and female-health being a vastly underinvested area. This creates a blind spot in the market which we intend to meet.

Screenshot 2022-05-04 at 14.34_edited.jpg


We want to provide customers with a “thermometer” for pregnancy testing, being easy to interpret, hygienic to use and 99% accurate at the day of expected menstruation. This in turn will increase convenience-levels, reduce our customer's spendings on their reproductive health, minimise the risk of miss-interpreting the results, and lastly, be beneficial for the environment.

Once successfully developed, we plan to employ the same technology onto other diagnostic areas where reusability would be advantageous.

Screenshot 2021-09-10 at 14.57.18.png


The pregnancy test is the most commonly used diagnostic test in the world where the market is expected to be worth $1.5 Billion. Still, no major innovation has occurred since the first at home pregnancy test entered the market in 1976. Until now...

Want to learn more? Get in touch by sending us an e-mail

bottom of page